What topical agents are recommended for treating lumbar back pain in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Topical Agents for Low Back Pain

Topical agents are NOT recommended as primary therapy for low back pain, with the exception of topical capsaicin for chronic low back pain with a neuropathic component. The 2017 American College of Physicians guideline explicitly states it does not address topical pharmacologic therapies for low back pain 1, and current evidence shows topical NSAIDs are likely less effective than oral alternatives for this condition.

Evidence-Based Recommendations

For Acute Low Back Pain

  • Topical NSAIDs (e.g., diclofenac gel) should NOT be used - A 2024 randomized controlled trial demonstrated that topical diclofenac was significantly less efficacious than oral ibuprofen for acute nonradicular musculoskeletal low back pain, with improvement scores of 6.4 points versus 10.1 points respectively 2
  • The combination of topical diclofenac plus oral ibuprofen showed no additive benefit over oral ibuprofen alone 2

For Chronic Low Back Pain

  • Topical capsaicin may be considered - One guideline from 2026 recommended topical capsaicin for chronic low back pain 3, though this represents only 1 of 15 guidelines addressing chronic low back pain pharmacotherapy
  • Topical NSAIDs received mostly neutral recommendations across guidelines, with limited supporting evidence 3

For Neuropathic/Radicular Low Back Pain

  • Topical agents warrant consideration when neuropathic mechanisms are present:
    • Capsaicin 8% patch and lidocaine 5% medicated plaster may be valuable for the neuropathic component of low back pain 4
    • A case series showed promising results with a multi-mechanistic topical formulation (containing diclofenac, ibuprofen, baclofen, cyclobenzaprine, bupivacaine, gabapentin, and pentoxifylline) for radicular pain, achieving 30-40% improvement 5
    • However, these are based on low-quality evidence (case series and open studies) rather than rigorous trials

Clinical Algorithm

Step 1: Determine pain type

  • Nonradicular mechanical low back pain → Do not use topicals; use oral NSAIDs or skeletal muscle relaxants 1
  • Chronic low back pain with neuropathic features (burning, shooting pain, dermatomal distribution) → Consider topical capsaicin or lidocaine as adjunctive therapy 4

Step 2: If considering topicals despite limited evidence:

  • Use topical capsaicin for chronic low back pain only
  • Reserve lidocaine patches for clearly identified neuropathic/radicular components
  • Avoid topical NSAIDs as monotherapy - they underperform oral NSAIDs 2

Critical Pitfalls

  1. Do not substitute topical NSAIDs for oral NSAIDs in acute low back pain - The evidence clearly shows inferior efficacy 2

  2. Recognize that most low back pain guidelines do not address topicals - The major 2017 ACP guideline explicitly excluded topical therapies from its scope 1, suggesting insufficient evidence for routine recommendation

  3. Topical agents do not address the underlying pathophysiology of most mechanical low back pain, which responds better to exercise, NSAIDs, and activity modification 1

  4. The neuropathic component of low back pain is often under-recognized 4 - If present, this is the only scenario where topicals have a reasonable evidence base

Practical Considerations

While newer research suggests topical analgesics may have a role in multimodal pain management 6, 7, the evidence for low back pain specifically remains weak. The 2021 PEER systematic review found only one trial of topical NSAIDs that showed similar benefit to placebo 8.

Bottom line: Prioritize oral NSAIDs, exercise therapy, and other evidence-based interventions per ACP guidelines 1. Reserve topical capsaicin or lidocaine exclusively for chronic low back pain with documented neuropathic features, and only as adjunctive therapy, not first-line treatment.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.